Expressly Does Not Require Being Expressed: Fed. Circuit Finds Salary Costs for Lobbying are Expressly Unallowable
Client Alert | 1 min read | 10.22.19
In Raytheon Co. v. Sec’y of Def., No. 2018-2371 (Fed. Cir. Sept. 18, 2019), the Federal Circuit affirmed the ASBCA’s decision that salary costs for lobbying activities are expressly unallowable under FAR 31.205-22. Raytheon argued that salary costs of employees who participate in lobbying activities are not “expressly unallowable” under FAR 31.001, because FAR 31.205-22 only generically refers to “costs associated with [lobbying activities]” and does not mention or identify in-house salary costs “by name.” The court disagreed, focusing on the definition of an “expressly unallowable cost” and concluding that “a particular item or type of cost . . . specifically named and identified as unallowable,” includes costs unambiguously falling within a generic description of a “type” of unallowable cost. According to the court, salaries of corporate personnel involved in lobbying are a prototypical lobbying expense, and, therefore, unambiguously “costs associated with” lobbying and “expressly unallowable.” The court also rejected various Raytheon arguments based on prior amendments to the lobbying cost principle and textual comparisons to other cost principles.
Because the Court concluded that salary costs for associated with lobbying are themselves “expressly unallowable,” it did not address Raytheon’s challenge to the Board’s alternative holding that even “directly associated costs” of an unallowable activity are “expressly unallowable,” subject to the penalties provided under FAR 42.709-1(a)(1).
Contacts
Insights
Client Alert | 2 min read | 12.16.25
ASBCA’s FY 2025 Report – A Look at the Numbers
Every year since 1979, the Armed Services Board of Contract Appeals (ASBCA) has issued a Report of Transactions and Proceedings (Report), which provides helpful statistics for contractors and practitioners regarding the ASBCA’s docket and success rates for contractor litigation and ADR. The ASBCA published its FY 2025 Report on October 30, 2025.
Client Alert | 11 min read | 12.15.25
New York LLC Transparency Act: Key Requirements and Deadlines
Client Alert | 7 min read | 12.15.25
The New EU “Pharma Package:” EU Reaches Landmark Deal on Pharma Package
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality


